Rubia, Mary Ann .

HRN: 12-54-12  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/29/2024
CEFUROXIME 750MG (VIAL)
11/29/2024
11/30/2024
IV
750mg
Q8 X 3 Doses
Post OP Prophylaxis
Rejected 

 Indication:  Prophylaxis    Type of Infection:  Reproductive Tract    Compliance to guidelines: Non-compliant To Guidelines